Drugs / GPRC5D CAR-T cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07365059 | Jan 2026 → Jan 2029 expected | plasma cell neoplasm | Qi deng | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GPRC5D CAR-T cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07365059 ↗ |
| Modality | Cell therapy | “GPRC5D CAR-T cell” NCT07365059 ↗ |
| Route | Intravenous | “intravenous infusion” NCT07365059 ↗ |
| Target | GPRC5D | “GPRC5D CAR-T cell” NCT07365059 ↗ |